Among the victims was the Hula painted frog, an amphibian found only in northern Israel. Last seen in the 1950s, it had ...
FDA IND clearance enables U.S. site activation for the ongoing Phase I C-1101-101 trial, with initial dosing already completed in Australia and near-term plans to begin treating U.S. patients. C-1101 ...
YouTube on MSN
We want to retract our own paper
My colleagues and I have done something unusual: we’ve asked to retract our own paper. What follows is a transparent ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced a strategic research ...
Consano Bio, Inc., a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions, today announced that the U.S. Food and Drug ...
Trip Jaunt on MSN
In Martin County, Nature Is Part of the Plan
Martin County gives you the version of Florida many travellers hope still exists: beaches that feel natural, waterways that ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing ...
Consano Bio receives US FDA IND clearance to expand the C-1101 chronic sciatica clinical development programme into US: Burlington, Massachusetts Tuesday, July 21, 2026, 14:00 Hrs ...
Tract Bio ("Tract"), a biotechnology company discovering and developing novel therapies for cancer and inflammatory disease, today announced presentations at the American Association for Cancer ...
If you belong to the group of people who have watched an orchid slowly decline despite your best efforts, take heart,” says ...
The American chestnut tree was a dominant and iconic species in many Appalachian forests until it was devastated by an introduced fungus from Asia called chestnut blight. A majestic forest tree, an ...
Morning Overview on MSN
An experimental Alzheimer’s immune therapy cleared its first safety trial with positive results
An experimental antibody designed to briefly block the immune checkpoint PD-L1 in the brain has cleared its first human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results